Biological and clinical effects of abemaciclib in a phase 2 neoadjuvant study for postmenopausal patients with HR+/HER2- breast cancer.
暂无分享,去创建一个
P. Fasching | A. Schneeweiss | J. García-Saenz | M. Colleoni | E. Petru | S. Hurvitz | D. Slamon | V. Guarneri | S. Barriga | M. Fernández Abad | T. Costigan | C. Caldwell